cyanogen bromide has been researched along with Acute Confusional Senile Dementia in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 4 (57.14) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Axelsen, PH; Furman, R; Komatsu, H; Ng, SCW | 1 |
| Benson, MD; Farlow, M; Ghetti, B; Liepnieks, JJ; Roses, AD | 1 |
| Ball, MJ; Clarke, S; Cotter, RJ; Heinrikson, RL; Lowenson, JD; Reardon, IM; Roher, AE; Wang, R; Wolkow, C; Zürcher-Neely, HA | 1 |
| Dean, GE; McLaughlin, L; Zemlan, FP | 1 |
| Abramowski, D; Beach, TG; Brune, D; Kalback, WM; Kokjohn, TA; Kuo, YM; Lopez, JC; Roher, AE; Staufenbiel, M; Sturchler-Pierrat, C; Sue, LI | 1 |
| Blades, D; Cheung, T; Fairbanks, MB; Gonzalez-De Whitt, PA; Heinrikson, RL; Palmert, MR; Pasternack, JM; Usiak, M; Wang, R; Zurcher-Neely, H | 1 |
| Bakalis, S; Duffy, L; Kosik, KS; Neve, RL; Orecchio, LD | 1 |
7 other study(ies) available for cyanogen bromide and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Quantitative Mass Spectrometric Assay of Whole and CNBr-Cleaved Amyloid-β Peptides in Human Brain.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amino Acid Sequence; Amyloid beta-Peptides; Brain Chemistry; Chromatography, High Pressure Liquid; Cyanogen Bromide; Female; Humans; Limit of Detection; Male; Mass Spectrometry; Peptide Fragments; Protein Processing, Post-Translational; Reference Standards | 2020 |
Characterization of amyloid fibril beta-peptide in familial Alzheimer's disease with APP717 mutations.
Topics: Alzheimer Disease; Amino Acid Sequence; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Brain; Brain Chemistry; Cerebral Cortex; Cyanogen Bromide; Humans; Molecular Sequence Data; Peptide Fragments; Point Mutation | 1993 |
Structural alterations in the peptide backbone of beta-amyloid core protein may account for its deposition and stability in Alzheimer's disease.
Topics: Alzheimer Disease; Amino Acid Sequence; Amyloid beta-Peptides; Aspartic Acid; Brain; Brain Chemistry; Centrifugation, Density Gradient; Cerebrovascular Circulation; Chromatography, Gel; Chromatography, High Pressure Liquid; Cyanogen Bromide; Humans; Meninges; Molecular Sequence Data; Muscle, Smooth, Vascular; Peptide Fragments; Peptides; Protein Processing, Post-Translational; Ultracentrifugation | 1993 |
Identification of microtubule-associated protein tau isoforms in Alzheimer's paired helical filaments.
Topics: Adult; Alzheimer Disease; Antibodies, Monoclonal; Cyanogen Bromide; Electrophoresis, Polyacrylamide Gel; Epitope Mapping; Humans; Immunoblotting; Immunohistochemistry; Isomerism; Nerve Fibers; tau Proteins | 1997 |
Comparative analysis of amyloid-beta chemical structure and amyloid plaque morphology of transgenic mouse and Alzheimer's disease brains.
Topics: Alzheimer Disease; Amino Acid Sequence; Amyloid; Amyloid beta-Peptides; Animals; Brain; Brain Chemistry; Chromatography, High Pressure Liquid; Cyanogen Bromide; Humans; Mice; Mice, Transgenic; Molecular Weight; Peptide Fragments; Plaque, Amyloid; Trypsin | 2001 |
Alzheimer's disease and control brain contain soluble derivatives of the amyloid protein precursor that end within the beta amyloid protein region.
Topics: Alzheimer Disease; Amino Acid Sequence; Amyloid beta-Protein Precursor; Brain Chemistry; Cyanogen Bromide; Humans; Mass Spectrometry; Molecular Sequence Data; Peptide Fragments | 1992 |
Partial sequence of MAP2 in the region of a shared epitope with Alzheimer neurofibrillary tangles.
Topics: Alzheimer Disease; Amino Acid Sequence; Animals; Antibodies, Monoclonal; Base Sequence; Brain Chemistry; Cattle; Chromosome Mapping; Cyanogen Bromide; DNA; DNA Restriction Enzymes; Epitopes; Microtubule-Associated Proteins; Molecular Sequence Data | 1988 |